# Efficacy of Seluang Fish Oil (Rasbora Argyrotaenia) and Synbiotics Supplementation on CD4+CD25+ Foxp3+ T-regulator Cells, IL17/IL-10 Ratio, and Disease Activity in Systemic Lupus Erythematosus Patients

> **NCT06659068** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Universitas Sriwijaya** · enrollment: 40 (actual)

## Conditions studied

- Systemic Lupus Erythematosus (SLE)

## Interventions

- **DIETARY_SUPPLEMENT:** Seluang fish oil (Rasbora argyrotaenia) and synbiotic
- **DIETARY_SUPPLEMENT:** Placebo

## Key facts

- **NCT ID:** NCT06659068
- **Lead sponsor:** Universitas Sriwijaya
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2024-05-16
- **Primary completion:** 2024-12-31
- **Final completion:** 2025-01-31
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2024-10-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06659068

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06659068, "Efficacy of Seluang Fish Oil (Rasbora Argyrotaenia) and Synbiotics Supplementation on CD4+CD25+ Foxp3+ T-regulator Cells, IL17/IL-10 Ratio, and Disease Activity in Systemic Lupus Erythematosus Patients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06659068. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*